Product NDC: | 0009-0039 |
Proprietary Name: | SOLU-MEDROL |
Non Proprietary Name: | methylprednisolone sodium succinate |
Active Ingredient(s): | 40 mg/mL & nbsp; methylprednisolone sodium succinate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0039 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011856 |
Marketing Category: | NDA |
Start Marketing Date: | 19590402 |
Package NDC: | 0009-0039-32 |
Package Description: | 25 VIAL, PATENT DELIVERY SYSTEM in 1 PACKAGE (0009-0039-32) > 1 mL in 1 VIAL, PATENT DELIVERY SYSTEM (0009-0039-33) |
NDC Code | 0009-0039-32 |
Proprietary Name | SOLU-MEDROL |
Package Description | 25 VIAL, PATENT DELIVERY SYSTEM in 1 PACKAGE (0009-0039-32) > 1 mL in 1 VIAL, PATENT DELIVERY SYSTEM (0009-0039-33) |
Product NDC | 0009-0039 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methylprednisolone sodium succinate |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19590402 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |